Total Payments
$929.24
2018 Payments
$29.23
Companies
20
Transactions
63
Payment Breakdown by Category
Food & Beverage$929.24 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $929.24 | 63 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $268.57 | 17 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $192.76 | 10 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $58.99 | 5 | $0 (2017) |
| Celgene Corporation | $47.60 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $43.80 | 3 | $0 (2017) |
| Amgen Inc. | $40.80 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $38.14 | 3 | $0 (2017) |
| Allergan Inc. | $29.23 | 2 | $0 (2018) |
| Eisai Inc. | $27.82 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.94 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $29.23 | 2 | Allergan Inc. ($29.23) |
| 2017 | $900.01 | 61 | Genentech USA, Inc. ($268.57) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/31/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/30/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Oncology | ||||||
| 10/09/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: Oncology | ||||||
| 10/05/2017 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: BioOncology | ||||||
| 10/05/2017 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: BioOncology | ||||||
| 09/21/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: BioOncology | ||||||
| 09/21/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: BioOncology | ||||||
| 09/14/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.62 | General |
| Category: Oncology | ||||||
| 09/12/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Hematology / Oncology | ||||||
| 09/08/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX, YONDELIS | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Oncology | ||||||
| 09/05/2017 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Oncology | ||||||
| 08/23/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $54.39 | General |
| Category: BioOncology | ||||||
| 08/23/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Oncology | ||||||
| 08/21/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Oncology | ||||||
| 08/21/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Oncology | ||||||
| 08/17/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2017 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Oncology | ||||||
| 08/04/2017 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Oncology | ||||||
| 07/31/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2017 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| Category: Oncology | ||||||
| 07/27/2017 | Genentech USA, Inc. | Zelboraf (Biological), Erivedge, COTELLIC | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: BioOncology | ||||||
About Dr. Stephen Kahanic, MD
Dr. Stephen Kahanic, MD is a Hematology & Oncology healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962474155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Kahanic, MD has received a total of $929.24 in payments from pharmaceutical and medical device companies, with $29.23 received in 2018. These payments were reported across 63 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($929.24).
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Sioux City, IA
- Active Since 02/02/2006
- Last Updated 01/07/2008
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1962474155
Products in Payments
- OPDIVO (Biological) $179.27
- TECENTRIQ (Biological) $108.14
- Avastin (Biological) $65.45
- Perjeta (Biological) $59.21
- Revlimid (Drug) $47.60
- IMBRUVICA (Drug) $31.99
- Neulasta (Biological) $28.82
- Lenvima (Drug) $27.82
- GILOTRIF (Drug) $24.94
- KEYTRUDA (Biological) $24.86
- SUSTOL (Drug) $24.08
- Stivarga (Drug) $23.34
- EMEND (Drug) $23.24
- NINLARO (Drug) $21.88
- Zelboraf (Biological) $21.25
- TEFLARO (Drug) $18.74
- VOTRIENT (Drug) $14.90
- VENCLEXTA (Biological) $14.52
- Optune (Device) $14.03
- Rubraca (Drug) $13.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Sioux City
Donald Wender, M.d, M.D
Hematology & Oncology — Payments: $25,556
Hematology & Oncology $25,556
Radha Rao, M.d, M.D
Hematology & Oncology — Payments: $4,538
Hematology & Oncology $4,538
Nibash Budhathoki, Mbbs, MBBS
Hematology & Oncology — Payments: $4,242
Hematology & Oncology $4,242
Chandana Javvaji, M.d, M.D
Hematology & Oncology — Payments: $943.69
Hematology & Oncology $943.69
John Michalak, M.d, M.D
Hematology & Oncology — Payments: $24.59
Hematology & Oncology $24.59